Sagent Pharmaceuticals CEO Sees Big Market Opportunity For His Firm |
![]() |
![]() |
By Staff and Wire Reports | |
Tuesday, 24 July 2012 12:50 | |
![]() In addition, he reveals that his firm is actively pursuing some M&A targets. "We’re also looking at products less than a hundred million that are with major pharma companies that these would be considered very small products for them and we’re starting to actively begin to talk to those companies about divesting those type of products." Sagent Pharmaceuticals was founded in 2006 by Yordon, with a mission to deliver an extensive portfolio of quality injectable products and fulfilling the evolving needs of the patients. Watch the full video interview: ![]() "Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'. Add this page to your favorite Social Bookmarking websites ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |